eamdacademy.org-tZ3q-1792911941-a796988024 1792911941 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2025 4 2 Ali Hassan Noor Siddiqui Bilal Khan Sana Malik 2025 10.68159/a796988024 https://eamdacademy.org/pub/journal/3/article/a796988024 Fuller A, Fan Z, Day C, Barlow C. Digital twin: Enabling technologies, challenges and open research. IEEE Access. 2020;8:108952-71. Barricelli BR, Casiraghi E, Fogli D. A survey on digital twin: Definitions, characteristics, applications, and design implications. IEEE Access. 2019;7:167653-71. Chen Y, Yang O, Sampat C, Bhalode P, Ramachandran R, Ierapetritou M, et al. Digital twins in pharmaceutical and biopharmaceutical manufacturing: a literature review. Processes. 2020;8(9):1088. Maharjan R, Kim NA, Kim KH, Jeong SH. Transformative roles of digital twins from drug discovery to continuous manufacturing: Pharmaceutical and biopharmaceutical perspectives. Int J Pharm X. 2025;9:100409. Moreno-Benito M, Lee KT, Kaydanov D, Verrier HM, Blackwood DO, Doshi P. Digital twin of a continuous direct compression line for drug product and process design using a hybrid flowsheet modelling approach. Int J Pharm. 2022;628:122336. Schütt M, Stamatopoulos K, Batchelor HK, Simmons MJ, Alexiadis A. Development of a digital twin of a tablet that mimics a real solid dosage form: Differences in the dissolution profile in conventional mini-USP II and a biorelevant colon model. Eur J Pharm Sci. 2022;179:106310. Fischer RP, Volpert A, Antonino P, Ahrens TD. Digital patient twins for personalized therapeutics and pharmaceutical manufacturing. Front Digit Health. 2024;5:1302338. Schmidt A, Helgers H, Lohmann LJ, Vetter F, Juckers A, Mouellef M, et al. Process analytical technology as key‐enabler for digital twins in continuous biomanufacturing. J Chem Technol Biotechnol. 2022;97(9):2336-46. O'Connor TF, Chatterjee S, Lam J, de la Ossa DH, Martinez-Peyrat L, Hoefnagel MH, et al. An examination of process models and model risk frameworks for pharmaceutical manufacturing. Int J Pharm X. 2024;8:100274. Moingeon P, Chenel M, Rousseau C, Voisin E, Guedj M. Virtual patients, digital twins and causal disease models: Paving the ground for in silico clinical trials. Drug Discov Today. 2023;28(7):103605. Destro F, Barolo M. A review on the modernization of pharmaceutical development and manufacturing–Trends, perspectives, and the role of mathematical modeling. Int J Pharm. 2022;620:121715. Schmidt A, Lütge J, Uhl A, Köster D, Strube J. Business cases for digital twins in biopharmaceutical manufacturing—Market overview, stakeholders, technologies in 2025 and beyond. Processes. 2025;13(5):1498. Beke ÁK, Gyürkés M, Nagy ZK, Marosi G, Farkas A. Digital twin of low dosage continuous powder blending–Artificial neural networks and residence time distribution models. Eur J Pharm Biopharm. 2021;169:64-77. Katsoulakis E, Wang Q, Wu H, Shahriyari L, Fletcher R, Liu J, et al. Digital twins for health: a scoping review. NPJ Digit Med. 2024;7(1):77. Wang H, Arulraj T, Ippolito A, Popel AS. From virtual patients to digital twins in immuno-oncology: lessons learned from mechanistic quantitative systems pharmacology modeling. NPJ Digit Med. 2024;7(1):189. Gaspar F, Terrier J, Jacot-Descombes C, Gosselin P, Ardoino V, Lenoir C, et al. Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban. Br J Clin Pharmacol. 2025;91(7):2057-69. Venkatesh KP, Brito G, Kamel Boulos MN. Health digital twins in life science and health care innovation. Annu Rev Pharmacol Toxicol. 2024;64(1):159-70. Elias M, König M. A digital twin of glimepiride for personalized and stratified diabetes treatment. Front Pharmacol. 2025;16:1686415. Diab S, Bano G, Christodoulou C, Hodnett N, Benedetti A, Andersson M, et al. Application of a system model for continuous manufacturing of an active pharmaceutical ingredient in an industrial environment. J Pharm Innov. 2022;17(4):1333-46. Hengelbrock A, Helgers H, Schmidt A, Vetter FL, Juckers A, Rosengarten JF, et al. Digital twin for HIV-gag VLP production in HEK293 cells. Processes. 2022;10(5):866. Helgers H, Schmidt A, Strube J. Towards autonomous process control—Digital twin for CHO cell-based antibody manufacturing using a dynamic metabolic model. Processes. 2022;10(2):316. Patil RS, Kulkarni SB, Gaikwad VL. Artificial intelligence in pharmaceutical regulatory affairs. Drug Discov Today. 2023;28(9):103700. Niazi SK. Regulatory perspectives for AI/ML implementation in pharmaceutical GMP environments. Pharmaceuticals. 2025;18(6):901. Vargas JM, Nielsen S, Cárdenas V, Gonzalez A, Aymat EY, Almodovar E, et al. Process analytical technology in continuous manufacturing of a commercial pharmaceutical product. Int J Pharm. 2018;538(1-2):167-78. Jajcevic D, Remmelgas J, Toson P, Matić M, Hörmann-Kincses T, Beretta M, et al. Development of a high-fidelity digital twin using the discrete element method for a continuous direct compression process. Part 1. Calibration workflow. Int J Pharm. 2024;666:124796. Jajcevic D, Remmelgas J, Toson P, Matić M, Hörmann-Kincses T, Beretta M, et al. Development of a high-fidelity digital twin using the discrete element method for a continuous direct compression process. Part 2. Validation of calibration workflow. Int J Pharm. 2024;666:124797. Helgers H, Hengelbrock A, Rosengarten JF, Stitz J, Schmidt A, Strube J. Towards autonomous process control—digital twin for hiv-gag vlp production in hek293 cells using a dynamic metabolic model. Processes. 2022;10(10):2015. Hengelbrock A, Probst F, Baukmann S, Uhl A, Tschorn N, Stitz J, et al. Digital twin for continuous production of virus-like particles toward autonomous operation. ACS Omega. 2024;9(32):34990-5013. Subramanian K. Digital twin for drug discovery and development—the virtual liver. J Indian Inst Sci. 2020;100(4):653-62.